story of the week
First-in-Human HER2-Targeted Bispecific Antibody KN026 for HER2-Positive Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study
Clin. Cancer Res 2022 Jan 04;[EPub Ahead of Print], J Zhang, D Ji, L Cai, H Yao, M Yan, X Wang, W Shen, Y Du, H Pang, X Lai, H Zeng, J Huang, Y Sun, X Peng, J Xu, J Yang, F Yang, T Xu, X HuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.